Stem Cells For Hair Regeneration

April 12, 2018
Download as PDF Single Release RSS Feed
Facebook Twitter Google Digg Reddit LinkedIn Email

Medical clinic and research facility Olympus Stem Cells Pty Ltd, based in Sydney Olympic Park, NSW, Australia, are pleased to announce a significant breakthrough in Hair Regeneration as a result of Alopecia Androgenetica (Baldness). Olympus Stem Cell are achieving up to 6 million viable stem cells per gram of tissue sourced from mini-liposuction of abdominal fat. No longer does a strip of follicle bearing scalp need to be harvested from the back of the head. The procured stem cells are injected into the scalp to stimulate existing hair follicles that are laying dormant. Stem cell numbers and viability are already known with similar stem cell treatments for a variety of conditions that are managed by Olympus Stem Cell Pty Ltd. A Muse Cell Analyser measures stem cell numbers and viability.

Olympus Stem Cell founder, Professor Russell Vickers has already been awarded a USA and global patent for the use of Zinc Thymulin in Hair Regeneration.

The International Application is published under the Patent Cooperation Treaty (PCT). The International Publication Number is WO 2017/210726 A1.

The patented formula of Zinc Thymulin is to regenerate hair lost as a result of Androgenic Alopecia. Stem Cell treatment is being used to enhance the effects and leads to more rapid hair re-growth.

More details can be obtained from http://www.olympusstemcells.com.au and http://www.clinicalstemcells.com.

The Director of Olympus Stem Cells, Associate Professor Russell Vickers, is an acknowledged world authority in the use of stem cells to treat neuropathic pain, dry eyes (keratoconjunctivitis sicca), dry mouth (xerostomia), symptoms of MS related to facial pain and osteoarthritis of the Temporomandibular joint.

Professor Vickers has co-discovered the use of a Zinc extract (in this case Zinc Thymulin used as a topical solution) and combined with stem cells to regenerate hair lost as a result of androgenic alopecia.

He is pleased to offer stem cell services including consultations and treatment amongst the 5 medical centres in Sydney Australia. Professor Russell Vickers has published extensively on the use of stem cells in neuropathic facial pain, stem cell protocols and is a leader in his field. He is conducting clinical treatment of Alopecia patients with stem cells harvested from the abdomen. The results of the Zinc Thymulin have been published in the peer reviewed Hair Restoration journal, Hair Therapy and Transplantation (see references). The results of Stem Cell Treatment has been published by him.

Professor Vickers sources the abdominal fat for adipose derived stem cells. He processes the fat and obtains stem cell concentrations that are extremely generous in numbers and quality. As a consultant surgeon he then delivers the stem cells to the anatomical area requiring the specific treatment, in this case the area of hair loss. The stem cells are injected supragaleal.

Associate Professor Vickers utilises a vast array of medical scientific equipment in his quest to offer the very best of stem cell treatment. For validation he uses the Muse Cell Analyser and has achieved 100% of stem cell viability. Additionally Olympus Stem Cells Pty Ltd has the availability of its own Mass Spectrometer and cell counting technology. In many conditions Stem Cell Therapy is a highly effective means of alleviating pain and discomfort for people suffering a variety of conditions ranging from MS to neuropathic facial pain. Professor Vickers has published in peer reviewed journals the efficacy of his treatment.

Olympus Stem Cells are proud to be one of Sydney's best Stem Cell and Hair loss providers, with a proven track record of providing safe, effective treatment and expert care for their patients. Olympus has a strong focus on research and development and is working hard to constantly further the advancement of stem cell techniques around the world. Their research has been published internationally in peer-reviewed medical and science journals, plus their laboratory boasts some of the best state-of-the-art biotechnology equipment in Australia.

Olympus Stem Cells Pty Ltd is one of the few companies undertaking ground breaking stem cell treatment in Australia and the Asia-Pacific region.

More information on the Olympus clinics and the work that they do can be obtained at http://www.olympushealthgroup.com.au.

Associate Professor Vickers' recent research publications pertaining to genetics, stem cells, hair loss and facial pain are extensive. These publications include Human Brain Mapping, the Australian Endodontic Journal, Hair Therapy and Transplantation, The Journal of Neuroscience, Diagnosing Dental and Orofacial Pain, the Journal of the Australian Society of Cosmetic Chemists, Medicine Today (The Journal of the Royal Australian College of General Practitioners), the Open Journal of Dentistry and Oral Medicine, and the Journal of Pain Research. More information on Associate Professor Vickers' work can be obtained at http://www.clinicalstemcells.com.

Contact Olympus Stem Cells Pty Ltd:

Professor Russell Vickers
+61 4277 11 888
[email protected]
Olympus Stem Cell Centre, Sydney Olympic Park, 5 Australia Avenue, Sydney Olympic Park, NSW, Australia



SOURCE: Press Advantage [Link]

Download as PDF Single Release RSS Feed
Facebook Twitter Google Digg Reddit LinkedIn Email

About Olympus Stem Cells Pty Ltd:

Olympus Stem Cells Pty Ltd are a clinical research and development biotech company engaged in stem cell therapy in Sydney, Australia.

Contact Olympus Stem Cells Pty Ltd:

Professor Russell Vickers
Olympus Stem Cell Centre,
Sydney Olympic Park,
5 Australia Avenue,
Sydney Olympic Park,
NSW, Australia.
+61 4277 11 888
http://www.olympusstemcells.com.au

This News Release Was Picked Up By These Local News Sites:

Digital Journal
FinancialContent
FinancialContent
FinancialContent

Additional News Releases From Olympus Stem Cells Pty Ltd:

April 12, 2018Olympus Stem Cells Pty Ltd Australia Demonstrating Superior Stem Cell Numbers and Viability in Treatment for Neuropathy

April 04, 2018Dry Mouth from Sjogren’s Syndrome or Head and Neck Radiation: Olympus Stem Cells Advise Technical Considerations in Surgery

April 03, 2018Dry Eyes and Stem Cells: Olympus Stem Cells Advise Technical Considerations in Surgery

April 02, 2018Olympus Stem Cells Using Zinc Thymulin, Micro-Fat Grafting and Stem Cells for Baldness

April 02, 2018Olympus Stem Cells Using Palmitoylethanolamide (PEA) and Stem Cells for Control of Disabling Facial Neuropathic Pain

March 26, 2018Olympus Stem Cells Pty Ltd Highlight Relationship Between Goblet Cells, Neuropathic Pain and Post LASIK Dry Eye Syndrome

March 26, 2018Olympus Stem Cells Pty Ltd Highlight Relationship Between Neural Crest Cells and Neuropathic Pain in Empty Nose Syndrome

March 19, 2018Olympus Genetics Pty Ltd Presents The Invitae Proactive Genetic Testing Panel to Mackay Oral and MaxilloFacial Surgery Under Leadership of Dr Anthony Oliver at Mackay, Queensland, Australia

March 19, 2018Clinical Stem Cells Pty Ltd Awarded USA and Worldwide Patent for Hair Regeneration